|
The Glasgow-Blatchford bleeding score (GBS) is a screening tool to assess the likelihood that a patient with an acute upper gastrointestinal bleeding (UGIB) will need to have medical intervention such as a blood transfusion or endoscopic intervention.〔(【引用サイトリンク】title=A risk score to predict need for treatment for uppergastrointestinal haemorrhage )〕 The tool may be able to identify patients who do not need to be admitted to hospital after a UGIB. Advantages of the GBS over the Rockall score, which assesses the risk of mortality in patients with UGIB, include a lack of subjective variables such as the severity of systemic diseases and the lack of a need for oesophagogastroduodenoscopy (OGD) to complete the score, a feature unique to the GBS. In a controlled study, 16% of patients presenting with UGIB had a GBS score of "0", considered low. Among these patients there were no deaths or interventions needed and the patients were able to be effectively treated in an outpatient setting.〔(【引用サイトリンク】title=Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation )〕〔() Stanley AJ et al. Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: Multicentre validation and prospective evaluation. Lancet 2009 Jan 3; 373:42. Summary Retrieved from Journal Watch 1/20/09 from Journal Watch Gastroenterology January 9, 2009〕 〔(【引用サイトリンク】title=Glasgow-Blatchford bleeding score )〕 == Criteria for Glasgow-Blatchford Score== The score is calculated using the table below: In the validation group, scores of 6 or more were associated with a greater than 50% risk of needing an intervention. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Glasgow-Blatchford score」の詳細全文を読む スポンサード リンク
|